Es Cushing Vte Risk Factor Evaluation

---
name: es-cushing-vte-risk-factor-evaluation
description: This skill guides evaluation of venous thromboembolism (VTE) risk factors in Cushing's syndrome patients to prevent thrombotic complications. Use when assessing a CS patient for thrombotic risk, especially perioperatively; triggers include preoperative assessment, postoperative period (within 4-6 weeks), or presence of CS with additional risk factors such as prior VTE, immobilization, malignancy, or estrogen use.
---

# Evaluation for Venous Thromboembolism Risk Factors in Cushing's Syndrome

## STEP 1 — Gather Information
Collect: surgical status (undergoing/planned surgery, recent surgery <4-6 weeks ago), history of VTE, current immobilization, active malignancy, estrogen use, obesity (BMI>30), known thrombophilias.

## STEP 2 — Rule In / Rule Out
First binary fork: Is the patient undergoing surgery or within 4-6 weeks postop OR has prior VTE, current immobilization, active malignancy, or estrogen use?
- If yes: Proceed to Step 3 for risk stratification.
- If no: Proceed to Step 3 for low-risk classification.

## STEP 3 — Classify or Stratify
If perioperative (surgery <4-6 weeks): Classify as Perioperative High Risk.
Else if non-perioperative: 
  - Classify as High Risk if prior VTE OR current immobilization OR active malignancy OR estrogen use.
  - Classify as Low Risk otherwise.

## STEP 4 — Decide
If Perioperative High Risk: Recommend perioperative pharmacologic prophylaxis (e.g., LMWH) unless contraindicated.
If High Risk (non-perioperative): Consider extended pharmacologic prophylaxis if hospitalized; otherwise, monitor for VTE signs and advise on early ambulation.
If Low Risk: Routine clinical monitoring; no specific VTE prophylaxis unless hospitalized for other reasons.

## Clinical Guardrails / Mimics / Pitfalls
Do not rely solely on D-dimer for VTE diagnosis in CS due to frequent false positives from inflammation. Avoid delaying prophylaxis in high-risk surgical CS patients due to bleeding risk concerns without hematology consultation. Remember that CS itself is a prothrombotic state; do not withhold prophylaxis based on normal coagulation studies.

## Concrete Clinical Example
A 45-year-old woman with active Cushing's disease (post-transsphenoidal surgery 2 weeks ago) presents for follow-up. She has no prior VTE, is ambulating well, no malignancy, not on estrogen. 
Step 1: Recent surgery <4-6 weeks ago -> yes.
Step 2: Perioperative yes -> proceed to Step 3.
Step 3: Classified as Perioperative High Risk.
Step 4: Recommend perioperative pharmacologic prophylaxis (e.g., enoxaparin 40 mg daily) until full ambulation.

**Source:** Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Nieman et al., 2015, DOI: 10.1210/jc.2015-1818